ArticleCureus2020

An Observational Study of Reduction in Glycemic Parameters and Liver Stiffness by Saroglitazar 4 mg in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.

Asis MitraPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.